7 Med India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-11-2024
- Paid Up Capital ₹ 0.30 M
as on 04-11-2024
- Company Age 11 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.00 Cr
as on 04-11-2024
- Revenue 17.17%
(FY 2023)
- Profit -28.40%
(FY 2023)
- Ebitda -10.26%
(FY 2023)
- Net Worth 8.44%
(FY 2023)
- Total Assets 14.28%
(FY 2023)
About 7 Med India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹20.00 Cr.
Vikas Verma, Rakesh Thakur, Ashish Tyagi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85499DL2013PTC261898
- Company No.
261898
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2013
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does 7 Med India Private Limited offer?
7 Med India Private Limited offers a wide range of products and services, including Career Guidance & Admission Services, Educational Services, Medical Surgery & Treatment Centres, Medical Treatment Services, Environment Protection & Auditing, Environmental Consultants.
Who are the key members and board of directors at 7 Med India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Verma  | Director | 06-Feb-2017 | Current |
| Rakesh Thakur | Director | 10-Dec-2013 | Current |
Ashish Tyagi  | Nominee Director | 12-Jun-2018 | Current |
| Mayank Sharma | Director | 02-Jun-2014 | Current |
Financial Performance and Corporate Structure Insights of 7 Med India.
7 Med India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.17% increase. The company also saw a substantial fall in profitability, with a 28.4% decrease in profit. The company's net worth moved up by a moderate rise of 8.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 7 Med India?
In 2023, 7 Med India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Integrated Renal Sciences Private LimitedActive 6 years 9 monthsVikas Verma, Rakesh Thakur and 2 more are mutual person
- Integrated Kidney Solutions Private LimitedActive 4 years 10 months
Vikas Verma, Rakesh Thakur and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Aug 2024 | ₹4.00 Cr | Open |
Others Creation Date: 31 Aug 2024 | ₹6.00 Cr | Open |
Yes Bank Limited Creation Date: 20 Feb 2024 | ₹10.00 Cr | Open |
How Many Employees Work at 7 Med India?
7 Med India has a workforce of 130 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 7 Med India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 7 Med India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
